Semaglutide GLP-1 injections can lower blood sugar levels, encourage weight loss, and lower the risk of cardiovascular events, among other advantages
J.PinkhasovaV.SyedM.KaoH.-Y.JozwickaA.ZhaoN.et al
Eligibility typically includes a BMI 35 kg/m with weight-related comorbidities (with lower thresholds for some ethnic groups), and treatment is usually provided through specialist weight management services with specific duration limits
Insurance Coverage: Whats Typically Allowed Most health plans limit coverage of Ozempic and the other GLP-1 medications to FDA-approved indicationsprimarily type 2 diabetes and, in some cases, chronic weight management
One major challenge is the accessibility and affordability of these services, which often require the involvement of healthcare professionals like dietitians, whose services may not be covered by insurance
Many women are overweight or obese at diagnosis, and we know that excess body fat predicts worse outcomes: higher recurrence rates, increased breast cancerspecific mortality, and higher overall mortality